Doyle Wealth Management Vericel Corp Transaction History
Doyle Wealth Management
- $1.16 Billion
- Q3 2022
Shares
2 transactions
Others Institutions Holding VCEL
# of Institutions
289Shares Held
49.5MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$331 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$143 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$133 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$98.8 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$92 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.94B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...